Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00479024 · ClinicalTrials.gov registry record
Follow-up Study to Previous CARE Trial
A clinical trial of Moderate to Severe Chronic Kidney Disease, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- 294
- Enrollment target
- 1
- Study location
NCT00479024: Completed study of Moderate to Severe Chronic Kidney Disease, sponsored by Bracco Diagnostics.
NCT00479024 is a study of Moderate to Severe Chronic Kidney Disease that has completed, run by Bracco Diagnostics. The registered enrollment target is 294 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00479024, a study of Moderate to Severe Chronic Kidney Disease, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- 294 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine comparative 1-year outcomes in renally impaired patients who previously underwent cardiac angiography with Isovue®-370 or Visipaque™ 320 as part of the IOP-104 trial protocol and were evaluable for determination of post-contrast significant renal injury (defined as \>25% increase in SCr or \>25% increase in cystatin C).
Conditions Studied
Interventions
- DRUG iodinated contrast agent
Study Locations (1)
Alabama
- Cardiovascular Associates - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-04 |
What the finished NCT00479024 record still lists
NCT00479024 is an observational study that tracks outcomes without assigning an intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Moderate to Severe Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which iodinated contrast agent is the first listed.
NCT00479024 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00479024 about?
NCT00479024 is a clinical study titled "Follow-up Study to Previous CARE Trial". To determine comparative 1-year outcomes in renally impaired patients who previously underwent cardiac angiography with Isovue®-370 or Visipaque™ 320 as part of the IOP-104 trial protocol and were evaluable for determination of post-contrast significant renal injury (defined as \>25% increase in SCr...
What is the current status of trial NCT00479024?
This trial is currently completed. The enrollment target is 294 participants. The study started on 2007-06. Estimated completion is 2008-04.
What conditions does trial NCT00479024 study?
This clinical trial studies the following conditions: Moderate to Severe Chronic Kidney Disease.
What interventions are being tested in trial NCT00479024?
The interventions under investigation include: iodinated contrast agent (DRUG).
Who is sponsoring clinical trial NCT00479024?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00479024 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia